Jalil, Angel Nadiyah D.
HRN: 20-79-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/29/2023
08/04/2023
PO
1ml
Q6
Oral Ulcers
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes